Cleveland Clinic Rheumatology

Cleveland Clinic offers expert diagnosis, treatment and rehabilitation for bone, joint or connective tissue disorders and rheumatic and immunologic diseases.

SLE With High Disease Activity & Potential Therapeutic Targets: Should LDA Be the Endpoint in Clinical Studies? Is Bimekizumab Safe and Effective in Ankylosing Spondylitis?

By Cleveland Clinic Rheumatology FEATURING Arthur Kavanaugh, John J. Cush

19 views

September 3, 2020

Comments 0

Login

Login

Join VuMedi

Cleveland Clinic Rheumatology

SLE With High Disease Activity & Potential Therapeutic Targets: Should LDA Be the Endpoint in Clinical Studies? Is Bimekizumab Safe and Effective in Ankylosing Spondylitis?

SLE Management: What Are the New Agents That Have Been Approved or H…

SLE: New Perspectives on Pathogenesis and Emerging Novel Therapies

Eye Disorders in Rheumatic Diseases: What Are the Recommendations on…

SLE With High Disease Activity & Potential Therapeutic Targets: Shou…

Managing Dermatologic Conditions in Rheumatology: How to Recognize a…

Advances in the Laboratory Aspects of Basic and Clinical Immunology …

A Primer on the Microbiome and Immune Health and Disease

Immunology for the Non-Immunologist: Understanding Immunology When Y…

Understanding B and T Cell Targeting in Autoimmune Diseases: Is Beli…

New and Emerging Treatments of Cutaneous Lupus

Advances in SLE and Vasculitis

Kinase Inhibition for IMIDs